Obstructive Sleep ApneaNCT02289625
Effects of Exercise Training on Cognitive Performance and Sympathetic Activity in Obstructive Sleep Apnea
A study testing Exercise Training in people with Obstructive Sleep Apnea, run by University of Sao Paulo General Hospital at 1 site in Brazil.
Trial summary
Abstract Obstructive sleep apnea syndrome (OSA) is characterized by complete or partial collapse of a narrowed pharynx and it's associated with reduction in cerebral blood flow, cardiovascular disease, and neuropsychological deficits and reduces survival. Read more about this study
- Who is it for?
- Ages 40 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Obstructive Sleep Apnea
- What is being tested?
- Exercise Training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteBrazil
- Study dates
- Oct 2010to 31 Dec 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- apparently healthy individual
- realize all tests
- participate in exercise training if selected by training group
Who cannot join
- Body mass index > 35 kg/m2
- cardiopulmonary disease
- chronic renal disease
- diabetes mellitus
- atrial fibrillation, pacemaker
- hypertension or renal failure
Show all 11Show fewer
- echocardiographic evidence of impaired left ventricular function (ejection fraction >45%)
- history of psychiatric disorders
- dementia or other neurodegenerative disorders
- a history of smoking or alcohol abuse (2 or more drinks per day)
- any sleep apnea treatment, story of circadian desynchrony (e.g. shift workers), incomplete 2 years of formal education, resting BP lower than 140/90 mmHg.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Exercise Training on Structure and Cerebral Metabolism, Cognition and Neurovascular Control in Individuals With Obstructive Sleep Apnea
Abstract
Obstructive sleep apnea syndrome (OSA) is characterized by complete or partial collapse of a narrowed pharynx and it's associated with reduction in cerebral blood flow, cardiovascular disease, and neuropsychological deficits and reduces survival. In patients with AOS structural, metabolic and hypoperfusion cerebral were associated not only with physiological functions but also with attention and executive function. There is a higher association between apnea hypopnea index and Mini-Mental State Examination in individuals with the exon 4 of APO E gene, indicating that exon 4 of APO E gene confers an increased risk for cognitive decline in individuals with sleep apnea. The analysis of presence and consequences of OSA in cerebral structure, inflammation and neurovascular control can permit a better investigation of abnormalities in these individuals and implement interventions to reduce the risk of development of cognitive and cardiovascular impairment. The non-pharmacological intervention through exercise training can represent an important strategy for improvement in cerebral alterations, cognition and reduction in sleep apnea index. The purpose of present study is investigate the volume and metabolism cerebral, neurovascular control, cognition and exon 4 of APO E gene and their
Read the detailed description
The investigators recruited both male and female sedentary individuals between 40 to 65 years from sleep laboratory that had recently performed sleep study. All non-menopause women were studied between the first and the fifth day after the onset of menstruation, since hormonal variability during the regular menstrual cycle may affect blood pressure (BP) or stress perception. Hypertension was carefully excluded in the groups. All subjects had at least three office BP measurements made by one of the study investigators, in addition three out of office BP measurements. Study subjects who had a body mass index (BMI) > 30 kg/m2, cardiopulmonary disease, chronic renal disease, diabetes mellitus, atrial fibrillation, pacemaker, hypertension, renal failure, echocardiographic evidence of impaired left ventricular function (ejection fraction >45%), history of psychiatric disorders, dementia or other neurodegenerative disorders, a history of smoking or alcohol abuse (2 or more drinks per day), any sleep apnea treatment, story of circadian desynchrony (e.g. shift workers), incomplete 2 years of formal education, resting blood pressure lower than 140/90 mmHg, body mass index (BMI) greater than 30 kg/m2. The study was approved by the institutional committee on human research and all subjects gave written, informed consent.
Daytime sleepiness. The chance of falling asleep in different situations was assessed by means of Epworth Sleepiness Scale.
Screening of Cognitive Functions. Brief cognitive functions were assessed by means of Mini Mental State Examination test (Folstein et al., 1975).
Intelligence Quotient. Intelligence was estimated by means of Kaufman Brief Intelligence Test using vocabulary and matrices subtests (Wagner et al., 2010).
Depression. Symptoms and depressive attitudes were assessed by means of Beck Depression Inventory that consists of 21 items, whose intensity varies from 0 to 3. Individuals with cutoffs < 10 (no or minimal depression) were included in the protocol (Beck et al., 1961).
Perception of Anxiety. Self-evaluation on the perception of anxiety was assessed by means of Beck Depression Anxiety Inventory (Beck et al., 1988).
Psychiatric Mental State. Current mental state was assessed by means of Self Reporting Questionnaire (SRQ-20). Individuals with cutoffs < 8 were included of the protocol.
Experimental Design. All subjects were healthy as confirmed by medical history and physical examinations, blood profile, echocardiographic evaluation and were not taking medications. All subjects abstained from caffeine for 24 hours before the study. All studies were performed in the post-absorptive state with exception of blood sample collection. Microneurography was performed in a quiet, temperature-controlled room on morning at approximately the same time of day. The right leg was positioned for microneurography. After an adequate nerve recording site was obtained, the subject rested quietly for 10 minutes. Baseline muscle sympathetic nerve activity, blood pressure, and heart rate were then recorded continuously for 4 minutes. Acute Color Word Stroop Test was then performed for 3 minutes. After 10 minutes of recovery all patients completed 30% hand grip isometric contraction followed by 2 minutes of brachial occlusion.
Sleep Study. All participants underwent overnight polysomnography as previously described (Ueno et al., 2009; Drager et al., 2009; Garcia et al., 2013). Sleep stages, apneas, hypopneas and arousals was defined and scored as previously described (Drager et al., 2009; Garcia et al., 2013).
The apnea-hypopnea index (AHI) was calculated by total number of respiratory events (apneas and hypopneas) per hour of sleep. Obstructive sleep apnea (OSA) was defined as a cessation of respiratory airflow for 10 seconds with thoracoabdominal effort, which was detected by Piezo respiratory effort sensor. Individuals with >70% of obstructive events were defined as individuals with OSA.
Muscle Sympathetic Nerve Activity. Muscle sympathetic nerve activity (MSNA) was directly recorded from the peroneal nerve using the technique of microneurography (Roveda et al., 2003; Ueno et al., 2009). Muscle sympathetic bursts were identified by visual inspection by a single investigator, blinded to the study protocol, and were expressed as burst frequency (bursts per min) and burst per 100 heart beats.
Heart rate and blood pressure. Heart rate (HR) was beat-by-beat continuously measured during the test obtained in a computer-recorded electrocardiographic tracing. Blood pressure (BP) was monitored noninvasively from an automatic leg blood pressure cuff (nondominant leg) using automated oscillometric device (Dixtal Biomedics, DX 2022). The systolic, diastolic and mean blood pressures were registered every minute of protocol.
Mental stress. Mental stress was elicited using modified version of CWST (During this test, subjects were shown a series of names of colors written in a different color ink from the color specified. Subjects were asked to identify the color of the ink, not read the word. Throughout each mental stress test, subjects were urged to work more quickly and gently chastised for incorrect answers.
Cardiopulmonary Exercise Test. Maximal exercise capacity was determined by means of a maximal progressive cardiopulmonary exercise test (SensorMedics - Vmax Analyzes Assembly, Encore 29S) on an electromagnetically braked cycle ergometer (Ergoline - Via Sprint 150 P), with work-rate constant increment (5 to 20W/min) at 60 to 70 rpm until exhaustion as previously described (Ueno et al., 2009). Peak VO2 was defined as the maximum attained VO2 at the end of the exercise period in which the subject could no longer maintain the cycle ergometer velocity at 60 rpm.
- Conditions
- Obstructive Sleep Apnea
- Being tested
- Exercise Training
- Keywords
- Obstructive Sleep Apnea, cognition, neurovascular function, brain metabolism, exercise training
- Medical subject headings
- Sleep Apnea, Obstructive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise TrainingOther
six month of Exercise training will be conducted in individuals with moderate to severe sleep apnea. The training include aerobic exercise, resistance exercise, flexibility.
| Study group | Role | What they receive |
|---|---|---|
| Attentional performance in OSA | Active comparator | To investigate the attentional performance and muscle sympathetic nerve activity (MSNA) response during Color Word Stroop Test (CWST) in patients with obstructive sleep apnea (OSA) before and after intervention with exercise training.Individuals with no other comorbidities (age=52±1 years, body mass index=29±0.4) were divided in control (n=15) and untreated OSA (n=20) defined by polysomnography. Receives: Other: Exercise Training |
| metaboreflex in OSA | Active comparator | To investigate the metaboreflex control of MSNA before and after intervention with exercise training in patients with obstructive sleep apnea.
Methods: Thirty-five patients underwent conventional polysomnography. The MSNA was assessed by microneurography technique. Beat to beat blood pressure was measured during 4 minutes at rest, 3 minutes of isometric exercise at 30% maximal voluntary contraction, followed by 2 minutes of occlusion of the circulation in previously exercised muscle. The metaboreflex sensitivity was calculated during the first and second minutes of circulatory occlusion when metaboreceptors are evaluated independently of central command and muscle mechanoreceptors. Receives: Other: Exercise Training |
What is being measured
The primary outcome is the main question the study is designed to answer.
effects of exercise training in patients with sleep apnea
structure and cerebral metabolism will be measure with Magnetic Resonance and regional blood flow. Cognition will be evaluate by neurocognitive tests. All measures will be applied before and after exercise training intervention.
Measured: 6 month of exercise training intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2014 (estimated)
- Study startOct 2010
- Primary completionOct 2019
- Study completion31 Dec 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Obstructive Sleep ApneaStudies of the same condition, open and under way.
- More trials run by University of Sao Paulo General HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Sao Paulo General Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Linda Massako Ueno, University of Sao Paulo General Hospital
- Investigators
- Linda M Ueno, Phd, Principal investigator, University of Sao Paulo General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02289625
- Sponsor's protocol ID
- 0833/10
- Status last verified
- Mar 2020
- First submitted
- 14 Oct 2014
- Last updated
- 26 Mar 2020
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Publications
Ueno-Pardi LM, Souza-Duran FL, Matheus L, Rodrigues AG, Barbosa ERF, Cunha PJ, Carneiro CG, Costa NA, Ono CR, Buchpiguel CA, Negrao CE, Lorenzi-Filho G, Busatto-Filho G. Effects of exercise training on brain metabolism and cognitive functioning in sleep apnea. Sci Rep. 2022 Jun 8;12(1):9453. doi: 10.1038/s41598-022-13115-2.
PubMed 35676287Goya TT, Ferreira-Silva R, Gara EM, Guerra RS, Barbosa ERF, Toschi-Dias E, Cunha PJ, Negrao CE, Lorenzi-Filho G, Ueno-Pardi LM. Exercise training reduces sympathetic nerve activity and improves executive performance in individuals with obstructive sleep apnea. Clinics (Sao Paulo). 2021 Sep 3;76:e2786. doi: 10.6061/clinics/2021/e2786. eCollection 2021.
PubMed 34495078Ueno-Pardi LM, Guerra RS, Goya TT, Silva RF, Gara EM, Lima MF, Nobre TS, Alves MJNN, Trombetta IC, Lorenzi-Filho G. Muscle Metaboreflex Control of Sympathetic Activity in Obstructive Sleep Apnea. Med Sci Sports Exerc. 2017 Jul;49(7):1424-1431. doi: 10.1249/MSS.0000000000001242.
PubMed 28230704Goya TT, Silva RF, Guerra RS, Lima MF, Barbosa ER, Cunha PJ, Lobo DM, Buchpiguel CA, Busatto-Filho G, Negrao CE, Lorenzi-Filho G, Ueno-Pardi LM. Increased Muscle Sympathetic Nerve Activity and Impaired Executive Performance Capacity in Obstructive Sleep Apnea. Sleep. 2016 Jan 1;39(1):25-33. doi: 10.5665/sleep.5310.
PubMed 26237773
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Exercise Training on Structure and Cerebral Metabolism, Cognition and Neurovascular Control in Individuals With Obstructive Sleep Apnea
- ClinicalTrials.gov ID
- NCT02289625
- Acronym / sponsor ID
- 0833/10
- Conditions
- Obstructive Sleep Apnea
- Keywords
- Obstructive Sleep Apnea, cognition, neurovascular function, brain metabolism, exercise training
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 70 participants (actual)
- Lead sponsor
- University of Sao Paulo General HospitalUniversity, hospital or other
- Study start
- Oct 2010
- Primary completion
- Oct 2019 (actual)
- Study completion
- 31 Dec 2022 (estimated)
- First posted
- 13 Nov 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Abstract
Obstructive sleep apnea syndrome (OSA) is characterized by complete or partial collapse of a narrowed pharynx and it's associated with reduction in cerebral blood flow, cardiovascular disease, and neuropsychological deficits and reduces survival. In patients with AOS structural, metabolic and hypoperfusion cerebral were associated not only with physiological functions but also with attention and executive function. There is a higher association between apnea hypopnea index and Mini-Mental State Examination in individuals with the exon 4 of APO E gene, indicating that exon 4 of APO E gene confers an increased risk for cognitive decline in individuals with sleep apnea. The analysis of presence and consequences of OSA in cerebral structure, inflammation and neurovascular control can permit a better investigation of abnormalities in these individuals and implement interventions to reduce the risk of development of cognitive and cardiovascular impairment. The non-pharmacological intervention through exercise training can represent an important strategy for improvement in cerebral alterations, cognition and reduction in sleep apnea index. The purpose of present study is investigate the volume and metabolism cerebral, neurovascular control, cognition and exon 4 of APO E gene and their
Detailed description
The investigators recruited both male and female sedentary individuals between 40 to 65 years from sleep laboratory that had recently performed sleep study. All non-menopause women were studied between the first and the fifth day after the onset of menstruation, since hormonal variability during the regular menstrual cycle may affect blood pressure (BP) or stress perception. Hypertension was carefully excluded in the groups. All subjects had at least three office BP measurements made by one of the study investigators, in addition three out of office BP measurements. Study subjects who had a body mass index (BMI) > 30 kg/m2, cardiopulmonary disease, chronic renal disease, diabetes mellitus, atrial fibrillation, pacemaker, hypertension, renal failure, echocardiographic evidence of impaired left ventricular function (ejection fraction >45%), history of psychiatric disorders, dementia or other neurodegenerative disorders, a history of smoking or alcohol abuse (2 or more drinks per day), any sleep apnea treatment, story of circadian desynchrony (e.g. shift workers), incomplete 2 years of formal education, resting blood pressure lower than 140/90 mmHg, body mass index (BMI) greater than 30 kg/m2. The study was approved by the institutional committee on human research and all subjects gave written, informed consent.
Daytime sleepiness. The chance of falling asleep in different situations was assessed by means of Epworth Sleepiness Scale.
Screening of Cognitive Functions. Brief cognitive functions were assessed by means of Mini Mental State Examination test (Folstein et al., 1975).
Intelligence Quotient. Intelligence was estimated by means of Kaufman Brief Intelligence Test using vocabulary and matrices subtests (Wagner et al., 2010).
Depression. Symptoms and depressive attitudes were assessed by means of Beck Depression Inventory that consists of 21 items, whose intensity varies from 0 to 3. Individuals with cutoffs < 10 (no or minimal depression) were included in the protocol (Beck et al., 1961).
Perception of Anxiety. Self-evaluation on the perception of anxiety was assessed by means of Beck Depression Anxiety Inventory (Beck et al., 1988).
Psychiatric Mental State. Current mental state was assessed by means of Self Reporting Questionnaire (SRQ-20). Individuals with cutoffs < 8 were included of the protocol.
Experimental Design. All subjects were healthy as confirmed by medical history and physical examinations, blood profile, echocardiographic evaluation and were not taking medications. All subjects abstained from caffeine for 24 hours before the study. All studies were performed in the post-absorptive state with exception of blood sample collection. Microneurography was performed in a quiet, temperature-controlled room on morning at approximately the same time of day. The right leg was positioned for microneurography. After an adequate nerve recording site was obtained, the subject rested quietly for 10 minutes. Baseline muscle sympathetic nerve activity, blood pressure, and heart rate were then recorded continuously for 4 minutes. Acute Color Word Stroop Test was then performed for 3 minutes. After 10 minutes of recovery all patients completed 30% hand grip isometric contraction followed by 2 minutes of brachial occlusion.
Sleep Study. All participants underwent overnight polysomnography as previously described (Ueno et al., 2009; Drager et al., 2009; Garcia et al., 2013). Sleep stages, apneas, hypopneas and arousals was defined and scored as previously described (Drager et al., 2009; Garcia et al., 2013).
The apnea-hypopnea index (AHI) was calculated by total number of respiratory events (apneas and hypopneas) per hour of sleep. Obstructive sleep apnea (OSA) was defined as a cessation of respiratory airflow for 10 seconds with thoracoabdominal effort, which was detected by Piezo respiratory effort sensor. Individuals with >70% of obstructive events were defined as individuals with OSA.
Muscle Sympathetic Nerve Activity. Muscle sympathetic nerve activity (MSNA) was directly recorded from the peroneal nerve using the technique of microneurography (Roveda et al., 2003; Ueno et al., 2009). Muscle sympathetic bursts were identified by visual inspection by a single investigator, blinded to the study protocol, and were expressed as burst frequency (bursts per min) and burst per 100 heart beats.
Heart rate and blood pressure. Heart rate (HR) was beat-by-beat continuously measured during the test obtained in a computer-recorded electrocardiographic tracing. Blood pressure (BP) was monitored noninvasively from an automatic leg blood pressure cuff (nondominant leg) using automated oscillometric device (Dixtal Biomedics, DX 2022). The systolic, diastolic and mean blood pressures were registered every minute of protocol.
Mental stress. Mental stress was elicited using modified version of CWST (During this test, subjects were shown a series of names of colors written in a different color ink from the color specified. Subjects were asked to identify the color of the ink, not read the word. Throughout each mental stress test, subjects were urged to work more quickly and gently chastised for incorrect answers.
Cardiopulmonary Exercise Test. Maximal exercise capacity was determined by means of a maximal progressive cardiopulmonary exercise test (SensorMedics - Vmax Analyzes Assembly, Encore 29S) on an electromagnetically braked cycle ergometer (Ergoline - Via Sprint 150 P), with work-rate constant increment (5 to 20W/min) at 60 to 70 rpm until exhaustion as previously described (Ueno et al., 2009). Peak VO2 was defined as the maximum attained VO2 at the end of the exercise period in which the subject could no longer maintain the cycle ergometer velocity at 60 rpm.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Attentional performance in OSA | Active comparator | Other: Exercise TrainingTo investigate the attentional performance and muscle sympathetic nerve activity (MSNA) response during Color Word Stroop Test (CWST) in patients with obstructive sleep apnea (OSA) before and after intervention with exercise training.Individuals with no other comorbidities (age=52±1 years, body mass index=29±0.4) were divided in control (n=15) and untreated OSA (n=20) defined by polysomnography. |
| metaboreflex in OSA | Active comparator | Other: Exercise TrainingTo investigate the metaboreflex control of MSNA before and after intervention with exercise training in patients with obstructive sleep apnea. Methods: Thirty-five patients underwent conventional polysomnography. The MSNA was assessed by microneurography technique. Beat to beat blood pressure was measured during 4 minutes at rest, 3 minutes of isometric exercise at 30% maximal voluntary contraction, followed by 2 minutes of occlusion of the circulation in previously exercised muscle. The metaboreflex sensitivity was calculated during the first and second minutes of circulatory occlusion when metaboreceptors are evaluated independently of central command and muscle mechanoreceptors. |
Who may qualify
- Ages
- 40 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- apparently healthy individual
- realize all tests
- participate in exercise training if selected by training group
Key exclusion criteria (11 listed)
- Body mass index > 35 kg/m2
- cardiopulmonary disease
- chronic renal disease
- diabetes mellitus
- atrial fibrillation, pacemaker
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise Trainingsix month of Exercise training will be conducted in individuals with moderate to severe sleep apnea. The training include aerobic exercise, resistance exercise, flexibility. | Other | Attentional performance in OSA, metaboreflex in OSA |
Primary outcome
effects of exercise training in patients with sleep apnea
Time frame: 6 month of exercise training intervention.
structure and cerebral metabolism will be measure with Magnetic Resonance and regional blood flow. Cognition will be evaluate by neurocognitive tests. All measures will be applied before and after exercise training intervention.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2020.
- Derived from this study: PubMed 35676287Ueno-Pardi LM, Souza-Duran FL, Matheus L, Rodrigues AG, Barbosa ERF, Cunha PJ, Carneiro CG, Costa NA, Ono CR, Buchpiguel CA, Negrao CE, Lorenzi-Filho G, Busatto-Filho G. Effects of exercise training on brain metabolism and cognitive functioning in sleep apnea. Sci Rep. 2022 Jun 8;12(1):9453. doi: 10.1038/s41598-022-13115-2.
- Derived from this study: PubMed 34495078Goya TT, Ferreira-Silva R, Gara EM, Guerra RS, Barbosa ERF, Toschi-Dias E, Cunha PJ, Negrao CE, Lorenzi-Filho G, Ueno-Pardi LM. Exercise training reduces sympathetic nerve activity and improves executive performance in individuals with obstructive sleep apnea. Clinics (Sao Paulo). 2021 Sep 3;76:e2786. doi: 10.6061/clinics/2021/e2786. eCollection 2021.
- Derived from this study: PubMed 28230704Ueno-Pardi LM, Guerra RS, Goya TT, Silva RF, Gara EM, Lima MF, Nobre TS, Alves MJNN, Trombetta IC, Lorenzi-Filho G. Muscle Metaboreflex Control of Sympathetic Activity in Obstructive Sleep Apnea. Med Sci Sports Exerc. 2017 Jul;49(7):1424-1431. doi: 10.1249/MSS.0000000000001242.
- Derived from this study: PubMed 26237773Goya TT, Silva RF, Guerra RS, Lima MF, Barbosa ER, Cunha PJ, Lobo DM, Buchpiguel CA, Busatto-Filho G, Negrao CE, Lorenzi-Filho G, Ueno-Pardi LM. Increased Muscle Sympathetic Nerve Activity and Impaired Executive Performance Capacity in Obstructive Sleep Apnea. Sleep. 2016 Jan 1;39(1):25-33. doi: 10.5665/sleep.5310.
- Individual participant dataSharing planned: No
Related trials for Obstructive Sleep Apnea
Not yet recruitingObservational study
Orthognathic Surgery and Obstructive Sleep Apnea Assessed by Mandibular Jaw Movement Monitoring (SUNRISE-ORTHO)
Obstructive Sleep Apnea, Sleep Apnea, Obstructive
Not yet recruitingObservational study
Association Between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea
Obstructive Sleep Apnea, Metabolic Dysfunction-Associated Steatotic Liver Disease
Not yet recruitingPhase 2/3
Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea
Sleep Apnoea, Obesity & Overweight
RecruitingObservational study
Development and Clinical Validation of Artificial Intelligence Algorithms for Sleep Staging and Obstructive Sleep Apnea Screening Based on a Large-Scale Model Trained on Multimodal Physiological Signals From Diverse Populations
Sleep Apnea, Obstructive, Sleep Staging
Not yet recruitingPhase 2
Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs
Obesity & Overweight, Respiratory Depression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Linda M Ueno, Phd principal investigator
University of Sao Paulo General Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise Training in people with Obstructive Sleep Apnea, run by University of Sao Paulo General Hospital at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 26 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
effects of exercise training in patients with sleep apnea (time frame: 6 month of exercise training intervention.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02289625, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2020; AzTrials last refreshed its copy on 2 Nov 2026.